We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$216M
AUM Growth
-$2.51M
Cap. Flow
-$7.44M
Cap. Flow %
-3.45%
Top 10 Hldgs %
35.07%
Holding
172
New
38
Increased
33
Reduced
47
Closed
40

Top Buys

Rank Stock Value
1
AMED
Amedisys
AMED
+$3.63M
2
CPRI icon
Capri Holdings
CPRI
+$3.52M
3
IDYA icon
IDEAYA Biosciences
IDYA
+$3.22M
4
SPLK
Splunk Inc
SPLK
+$3.13M
5
GPCR icon
Structure Therapeutics
GPCR
+$2.41M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$5.49M
2
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$3.86M
3
BKI
Black Knight, Inc. Common Stock
BKI
+$3.59M
4
MMP
Magellan Midstream Partners, L.P.
MMP
+$3.49M
5
AJRD
Aerojet Rocketdyne Holdings
AJRD
+$3.38M

Sector Composition

Rank Sector Weight
1 Healthcare 46.09%
2 Technology 13.85%
3 Consumer Discretionary 6.89%
4 Financials 3.51%
5 Communication Services 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCOM icon
76
Trip.com Group
TCOM
$29.1B
$711K 0.33%
20,329
-3,400
-14% -$128K
HTHT icon
77
Huazhu Hotels Group
HTHT
$12.8B
$707K 0.33%
17,929
-2,800
-14% -$118K
ROP icon
78
Roper Technologies
ROP
$39.5B
$684K 0.32%
1,413
-500
-26% -$245K
SE icon
79
Sea Limited
SE
$80.5B
$679K 0.31%
15,441
+3,600
+30% +$176K
PRKS icon
80
United Parks & Resorts
PRKS
$2B
$670K 0.31%
14,488
+1,200
+9% +$61K
CZR icon
81
Caesars Entertainment
CZR
$6.06B
$658K 0.3%
+14,200
New +$754K
PANW icon
82
Palo Alto Networks
PANW
$313B
$634K 0.29%
5,410
-1,000
-16% -$118K
ADBE icon
83
Adobe
ADBE
$105B
$625K 0.29%
1,225
-200
-14% -$105K
ELV icon
84
Elevance Health
ELV
$84.7B
$610K 0.28%
+1,400
New +$635K
UNH icon
85
UnitedHealth
UNH
$365B
$605K 0.28%
+1,200
New +$591K
BABA icon
86
Alibaba
BABA
$306B
$603K 0.28%
6,957
-900
-11% -$82.4K
IBN icon
87
ICICI Bank
IBN
$107B
$586K 0.27%
25,347
-4,200
-14% -$98.8K
RTX icon
88
RTX Corp
RTX
$302B
$583K 0.27%
+8,100
New +$694K
SRPT icon
89
Sarepta Therapeutics
SRPT
$1.92B
$580K 0.27%
4,781
-224
-4% -$25.3K
AKRO
90
DELISTED
Akero Therapeutics
AKRO
$577K 0.27%
+11,408
New +$531K
UBER icon
91
Uber
UBER
$160B
$575K 0.27%
+12,500
New +$571K
PCVX icon
92
Vaxcyte
PCVX
$8.81B
$573K 0.27%
11,248
-3,313
-23% -$163K
STNE icon
93
StoneCo
STNE
$2.42B
$569K 0.26%
53,330
– –
ASND icon
94
Ascendis Pharma A/S
ASND
$16.7B
$552K 0.26%
5,898
+1,723
+41% +$161K
HDB icon
95
HDFC Bank
HDB
$120B
$551K 0.26%
18,682
-1,000
-5% -$32.6K
CPT icon
96
Camden Property Trust
CPT
$10.9B
$549K 0.25%
+5,800
New +$617K
TRU icon
97
TransUnion
TRU
$15.4B
$546K 0.25%
+7,600
New +$596K
NFLX icon
98
Netflix
NFLX
$311B
$545K 0.25%
14,440
-2,000
-12% -$84.8K
CERE
99
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$543K 0.25%
+24,887
New +$623K
PLRX icon
100
Pliant Therapeutics
PLRX
$63.8M
$533K 0.25%
30,723
-3,312
-10% -$57.4K
2 3
4
5 6

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
PPG
Peak Planning Group Centennial, Colorado $361M AUM 22.01% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return

HighVista Strategies's Q3 2023 Portfolio in Review

As of Q3 2023, HighVista Strategies held 172 positions worth $216M, down 1.1% from $219M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

HighVista Strategies withdrew a net $7.44M in Q3 2023, closing 40 positions and reducing 47 holdings. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $5.49M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 47% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, HighVista Strategies opened a new position in Amedisys worth $3.67M.

  • HighVista Strategies's largest Q3 2023 buy was Amedisys: 39,250 shares worth $3.67M.
  • HighVista Strategies added most to Merus in Q3 2023, an estimated $2.15M increase.
  • HighVista Strategies's biggest Q3 2023 reduction was MoonLake Immunotherapeutics, cutting an estimated $3.86M.
  • HighVista Strategies fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $5.49M.
  • HighVista Strategies's ten largest holdings make up 35% of its $216M portfolio in Q3 2023.
  • HighVista Strategies opened 38 new positions and closed 40 in Q3 2023.
  • HighVista Strategies's portfolio value fell 1.1% quarter-over-quarter to $216M.

Based on HighVista Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.